rs1554770046

Variant summary

Our verdict is Likely pathogenic.
+9 Likely Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 9 classification points (ACMG Germline Pathogenicity v2019). PM1PM2PP3PP5_Strong

The NM_007327.4(GRIN1):c.1645A>C (p.Ser549Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★). Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.S549= (synonymous): Likely_benign (ClinVar VariationId 539842, 2 stars)

Frequency

Genomes: not found (cov: 33)

Consequence

GRIN1
NM_007327.4 missense

Scores

6
13

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:2

Conservation

PhyloP100: 6.79

Publications

1 publications found
Variant links:
Genes affected
GRIN1 (HGNC:4584): (glutamate ionotropic receptor NMDA type subunit 1) The protein encoded by this gene is a critical subunit of N-methyl-D-aspartate receptors, members of the glutamate receptor channel superfamily which are heteromeric protein complexes with multiple subunits arranged to form a ligand-gated ion channel. These subunits play a key role in the plasticity of synapses, which is believed to underlie memory and learning. Cell-specific factors are thought to control expression of different isoforms, possibly contributing to the functional diversity of the subunits. Alternatively spliced transcript variants have been described. [provided by RefSeq, Jul 2008]
GRIN1 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: PanelApp Australia, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive
    Inheritance: AR Classification: DEFINITIVE, MODERATE Submitted by: G2P, Ambry Genetics
  • developmental and epileptic encephalopathy 101
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • GRIN1-related complex neurodevelopmental disorder
    Inheritance: AR Classification: STRONG Submitted by: PanelApp Australia
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_007327.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Likely_pathogenic. The variant received 9 points.

PM1Mutational hot spot or critical domain
Missense neighbourhood hotspot (≥2 P/LP within ±8 AA, OR ≥ 5 vs. background) — PM1; In-domain: 0 pathogenic, 0 benign rare missense variants.; ±8 AA neighbourhood: 11 pathogenic, 0 benign (OR vs. background: 115.0).
PM2Absent/extremely low in population databases
Absent from gnomAD (AD/XL gene) — PM2; Absent from gnomAD at well-covered site (MOI: AD+AR) (threshold 0.0001) — PM2 moderate.
PP3Computational evidence supports damaging effect
Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — supporting evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Supporting).
PP5Reputable source reports pathogenic
ClinVar 2-star pathogenic — strong (PP5); ClinVar germline classification: Pathogenic/Likely Pathogenic, 2 star(s).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_007327.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

GRIN1 NM_007327.4
MANE Select
HGVSc / HGVSpc.1645A>Cp.Ser549Arg
Exon rankExon 12 of 20
missense
Prot: NP_015566.1UniProt: Q05586-1
GRIN1 NM_001437330.1
HGVSc / HGVSpc.1708A>Cp.Ser570Arg
Exon rankExon 13 of 21
missense
Prot: NP_001424259.1UniProt: Q05586-5
GRIN1 NM_001185090.2
HGVSc / HGVSpc.1708A>Cp.Ser570Arg
Exon rankExon 13 of 21
missense
Prot: NP_001172019.1UniProt: Q05586-6

Ensembl Transcripts

GRIN1 ENST00000371561.8
TSL:1MANE Select
HGVSc / HGVSpc.1645A>Cp.Ser549Arg
Exon rankExon 12 of 20
missense
Prot: ENSP00000360616.3UniProt: Q05586-1
GRIN1 ENST00000371553.8
TSL:1
HGVSc / HGVSpc.1708A>Cp.Ser570Arg
Exon rankExon 13 of 21
missense
Prot: ENSP00000360608.3UniProt: Q05586-6
GRIN1 ENST00000371560.5
TSL:1
HGVSc / HGVSpc.1708A>Cp.Ser570Arg
Exon rankExon 13 of 20
missense
Prot: ENSP00000360615.3UniProt: Q05586-7

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 3 sources
GnomAD3 genomes
Cov:33
GnomAD4 exome
Cov:33
GnomAD4 genome
Cov:33
Showing 3 sources

Case/control cohorts

CohortCasesControls
AFACANAFACAN
Epi25
(Epilepsy)
0.0000238 141958 0.00 066888
Showing 1 cohortAllele count / allele number. AF is computed from the counts for ASC (not provided by the source).

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
-
-
Inborn genetic diseases (1)
1
-
-
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant (1)

Computational Scores

AlphaGenome AVI
Pathogenic28
AlphaMissense
Pathogenic0.99
BayesDel_addAF
Pathogenic0.19D
BayesDel_noAF
Uncertain0.030
CADD
Pathogenic32
DANN
Uncertain1.0
DEOGEN2
Uncertain0.77D
Eigen
Uncertain0.43
Eigen_PC
Uncertain0.36
FATHMM_MKL
Uncertain0.92D
FuncVEP CTI
Pathogenic1.0
GPN-Star LLR
N/A-10
GPN-Star score
N/A10
LIST_S2
Uncertain0.95D
M_CAP
Pathogenic0.78D
MetaRNN
Pathogenic0.90D
MetaSVM
Uncertain-0.081T
Mutation Taster
N/A0/100disease causing (ClinVar)
MutationAssessor
Uncertain2.8M
PhyloP100
Uncertain6.8
popEVE
Uncertain-4.8
PrimateAI
Pathogenic0.92D
PROVEAN
Uncertain-4.0D
REVEL
Pathogenic0.70
Sift
Uncertain0.015D
Sift4G
Uncertain0.0030D
Varity_R
N/A0.72
VESM-3B
Benign-13
Showing 28 of 28 scores

Splicing Scores

Pangolin (max)
Benign0.010
SpliceAI score (max)
Benign0.060
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.